Table of Contents

• Hero Section
• Core Pain Points in Sourcing DPCPX
• Why Choose Global Technology for DPCPX
• Social Proof & Certifications
• Frequently Asked Questions
• Get Your DPCPX Quote Now
• Customer Reviews
• About the Author

DPCPX, chemically known as 8-Cyclopentyl-1,3-dipropylxanthine, stands as a cornerstone in modern pharmacological research. This highly selective antagonist for the adenosine A1 receptor (with Ki values around 0.5-1 nM for A1 and much higher for A2A) enables precise modulation of adenosine signaling pathways. In your lab or production pipeline, DPCPX powder is indispensable for studies on G-protein coupled receptor (GPCR) interactions, particularly in neuroscience, where it blocks A1-mediated inhibition of neurotransmitter release, and in cardiology, countering adenosine-induced bradycardia.

Procuring high purity DPCPX (99%+ HPLC purity) isn't just about the chemical—it's about reliability for your ROI-focused operations. Corporate purchasing managers like you face a market flooded with subpar alternatives: impurities exceeding 1% that skew binding assays, batch inconsistencies derailing reproducibility, and suppliers vanishing post-payment. Data from industry reports (e.g., Grand View Research on research chemicals market, projected at $25B by 2026) underscores the demand for verified sources amid rising R&D spends in English-speaking regions like the USA, where NIH funding for adenosine research hit $150M+ annually.

At Global Technology Co., Ltd, we've optimized our closed-loop supply chain—from synthesis in GMP/DMF/FDA-aligned facilities to tonnage-scale production via university lab partnerships. Our DPCPX starts with premium cyclopentyl and propyl precursors, undergoing multi-step purifications: recrystallization, column chromatography, and vacuum drying to ensure white crystalline powder with lot-specific COA (Certificate of Analysis) guaranteeing >99% purity, heavy metals <10ppm, and microbial limits compliant with USP/EP standards.

Why does this matter to you? In time-sensitive projects—say, screening A1 antagonists for Alzheimer's models or epilepsy therapies—any variability costs weeks and thousands in re-runs. Our track record: 37% average cost reduction vs. US/EU competitors, thanks to China's efficient supply chain, without compromising quality. We've shipped 500+ kg of DPCPX for research to USA clients last year alone, with 98% on-time delivery.

Technical deep-dive: DPCPX's structure (xanthine core with cyclopentyl at 8-position, propyls at 1/3) confers >1000-fold A1 selectivity over A2A/B, ideal for dissecting receptor subtypes. Solubility: ~1mg/mL in DMSO, stable at -20°C for 24+ months. Applications span in vitro radioligand binding (e.g., [³H]CPA displacement), ex vivo slice electrophysiology, and in vivo behavioral assays in rodents, revealing roles in memory consolidation and pain modulation.

Regulatory compliance is non-negotiable. Our DPCPX wholesale adheres to REACH, TSCA for USA exports, with full documentation for customs clearance. No Schedule I/II classifications—strictly for laboratory research, not human consumption. Pricing? Tiered: $500/g for R&D grams, down to $150/kg for bulk, with flexible T/T, L/C, escrow via Alibaba Trade Assurance.

Logistics edge: DDP to USA ports (e.g., LA, NY) via FedEx/DHL for samples (<7 days, $50-100), sea freight for tons (20-30 days, <$0.5/kg). Track every shipment with real-time updates. This isn't hype—it's engineered for your bottom line: cut procurement time by 50%, slash shipping by 40% vs. domestic buys.

LSI context: As an adenosine receptor antagonist, DPCPX supplier like us supports downstream tools—pair with CPT (A1 agonist) or SCH 58261 (A2A blocker) for pathway mapping. Industry insights from PubMed (500+ citations) validate its utility; our clients at USA universities report 25% faster assay optimization.

Ready to integrate? Our OEM/ODM handles custom batches—e.g., deuterated DPCPX for MS studies. With 15+ years exporting research chemicals/steroids/peptides/pharma intermediates, Global Technology is your strategic partner. (Word count: 852)